MARCIA CHIMINO: Open Payments
NPI 1790423150 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 26 payments from 9 companies in 2025. Trend: 2023 $1,484 · 2024 $697 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $204 |
| Orexo US, Inc. | 5 | $94 |
| PFIZER INC. | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Indivior Inc. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Valinor Pharma, LLC | 1 | $16 |
| Nalu Medical, Inc. | 1 | $15 |
Products named: QULIPTA, Zubsolv, NURTEC ODT, UBRELVY, RELISTOR, Belbuca, SUBLOCADE, XTAMPZA.
Industry payments across IN — which companies pay providers there.
